Internal J&J Docs Spark New Talcum Powder Ovarian Cancer Lawsuit News

Attorneys representing the victorious plaintiff at the heart of recent talcum powder ovarian cancer lawsuit news presented internal Johnson & Johnson documents during the trial with that proved the company marketed their talcum powder products with the knowledge that they had a causal link to an increased risk of ovarian cancer.

Monday, March 7, 2016 - Attorneys for the plaintiff in the talcum powder lawsuit filed before the City of St. Louis Circuit Court claim that internal Johnson & Johnson (J&J) documents proved that the defendants were long aware of the link between talcum powder and ovarian cancer. This evidence was different from a lot of the talcum powder ovarian cancer lawsuit news surrounding the materials plaintiffs will be presenting before the court as it is not necessarily focused on the scientific link between talcum powder and ovarian cancer. While talcum powder lawsuits nationwide are attempting to prove that a carcinogenic correlation does exist and is scientifically sound, the plaintiffs also intend to establish that J&J were aware of the research behind link between talcum powder and ovarian cancer and chose to market the product despite its hazardous effects.

The attorney for the plaintiff in the first talcum powder trial, which began on February 2, made reference to these documents at the start of the trial. The claims that Johnson & Johnson were aware of concrete links between talcum powder and ovarian cancer possibly for decades are comparably significant to proving that the product is linked to ovarian cancer as this type of intentional negligence can factor heavily into jury awards and settlement amounts. Following through on a stated goal reported in talcum powder cancer lawsuit news before the trial, the plaintiff's attorneys proved that J&J intentionally put profits before consumer health when it came to the marketing of talcum powder.

Leading up to the trial, J&J argued that they were not aware of any talcum powder ovarian cancer research that established a carcinogenic link with their talcum products. Instead, J&J is presented its own series of studies that it claimed proved no significant link between talcum powder and ovarian cancer. The healthcare company leaned on those studies to argue that while they may have been aware of allegations of a talcum powder ovarian cancer link, but it did not end up to be influential enough to sway the jurors.

The judge overseeing the case made talcum powder lawsuit news when he rejected a J&J proposal to dismiss the lawsuit a week before the litigation began, foreseeing a reasonable possibility given the facts that J&J could be ruled against by the jury. The plaintiff needed 9 of the 12 jury members to side with their arguments in order to land the victory in this initial and important St. Louis talcum powder ovarian cancer lawsuit.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.